Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities.


Journal

Pigment cell & melanoma research
ISSN: 1755-148X
Titre abrégé: Pigment Cell Melanoma Res
Pays: England
ID NLM: 101318927

Informations de publication

Date de publication:
05 2019
Historique:
received: 19 12 2018
revised: 17 01 2019
accepted: 27 01 2019
pubmed: 4 2 2019
medline: 17 7 2019
entrez: 4 2 2019
Statut: ppublish

Résumé

In February 2018, the Melanoma Research Foundation and the Moffitt Cancer Center hosted the Second Summit on Melanoma Central Nervous System (CNS) Metastases in Tampa, Florida. In this white paper, we outline the current status of basic science, translational, and clinical research into melanoma brain metastasis development and therapeutic management. We further outline the important challenges that remain for the field and the critical barriers that need to be overcome for continued progress to be made in this clinically difficult area.

Identifiants

pubmed: 30712316
doi: 10.1111/pcmr.12771
pmc: PMC7771318
mid: NIHMS1654497
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

458-469

Subventions

Organisme : NCI NIH HHS
ID : P30 CA010815
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA076292
Pays : United States
Organisme : Melanoma Research Foundation
Pays : International

Informations de copyright

© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Cell Rep. 2015 Nov 3;13(5):898-905
pubmed: 26565903
Clin Cancer Res. 2013 Oct 1;19(19):5320-8
pubmed: 24089445
Nature. 2015 Nov 5;527(7576):100-104
pubmed: 26479035
Melanoma Manag. 2015;2(3):241-254
pubmed: 26594316
Lancet Oncol. 2012 May;13(5):459-65
pubmed: 22456429
Lancet Oncol. 2018 Jan;19(1):e20-e32
pubmed: 29304358
Cancer Cell. 2013 Mar 18;23(3):302-15
pubmed: 23477830
Cell. 2014 Dec 18;159(7):1603-14
pubmed: 25525878
Mol Cancer Res. 2009 Sep;7(9):1438-45
pubmed: 19723875
N Engl J Med. 2012 Nov;367(18):1694-703
pubmed: 23020132
Pigment Cell Melanoma Res. 2016 Nov;29(6):627-642
pubmed: 27615400
N Engl J Med. 2016 Dec 29;375(26):2561-9
pubmed: 28029927
Clin Cancer Res. 2014 Nov 1;20(21):5537-46
pubmed: 24803579
Pigment Cell Melanoma Res. 2018 Jan;31(1):11-30
pubmed: 29049843
Drug Metab Dispos. 2018 May;46(5):658-666
pubmed: 29437873
Cancer. 2013 Aug 1;119(15):2737-46
pubmed: 23695963
Expert Rev Anticancer Ther. 2017 Apr;17(4):347-356
pubmed: 28277101
Cancers (Basel). 2018 Jun 11;10(6):
pubmed: 29891810
Lancet. 2015 Aug 1;386(9992):444-51
pubmed: 26037941
J Neurosurg. 2014 Jan;120(1):52-9
pubmed: 24160478
J Pharmacol Exp Ther. 2013 Mar;344(3):655-64
pubmed: 23249624
J Clin Invest. 2015 Apr;125(4):1459-70
pubmed: 25705882
Mol Ther. 2018 Jan 3;26(1):31-44
pubmed: 29103912
J Clin Invest. 2013 Mar;123(3):1371-81
pubmed: 23454771
Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):E1540-E1549
pubmed: 29386395
Int J Mol Sci. 2014 Jul 03;15(7):11832-46
pubmed: 24995696
Lancet Oncol. 2017 Jul;18(7):863-873
pubmed: 28592387
Expert Rev Neurother. 2016 Aug;16(8):903-14
pubmed: 27177183
Cancer Res. 2014 Dec 1;74(23):7037-47
pubmed: 25297634
J Clin Oncol. 2019 Jan 1;37(1):52-60
pubmed: 30407895
N Engl J Med. 2015 Jan 1;372(1):30-9
pubmed: 25399551
Oncogene. 2002 Feb 21;21(9):1450-60
pubmed: 11857088
Clin Exp Metastasis. 2017 Oct;34(6-7):401-410
pubmed: 29063238
J Neurooncol. 2014 Mar;117(1):33-42
pubmed: 24442402
Oncoimmunology. 2015 Jun 9;5(1):e1057388
pubmed: 26942067
Oncotarget. 2017 Oct 27;8(61):103671-103681
pubmed: 29262592
Lancet Oncol. 2016 Dec;17(12):1743-1754
pubmed: 27864013
Clin Cancer Res. 2013 Sep 1;19(17):4868-78
pubmed: 23833299
Pigment Cell Melanoma Res. 2014 Jul;27(4):590-600
pubmed: 24495407
Cancer. 2011 Apr 15;117(8):1711-20
pubmed: 21472718
Neurosurg Clin N Am. 1996 Jul;7(3):337-44
pubmed: 8823767
Proc Natl Acad Sci U S A. 2012 May 22;109(21):8253-8
pubmed: 22566612
Clin Cancer Res. 2016 Dec 1;22(23):5818-5828
pubmed: 27307593
Lancet Oncol. 2012 Nov;13(11):1087-95
pubmed: 23051966
Cancer Med. 2013 Feb;2(1):76-85
pubmed: 24133630
J Clin Oncol. 2013 May 10;31(14):1767-74
pubmed: 23569304
Clin Lung Cancer. 2017 Jul;18(4):354-363
pubmed: 28245967
Ann Oncol. 2016 Mar;27(3):434-41
pubmed: 26712903
JAMA Oncol. 2018 Aug 1;4(8):1123-1124
pubmed: 29327059
Lancet Oncol. 2018 May;19(5):672-681
pubmed: 29602646
Curr Opin Cell Biol. 2012 Feb;24(1):116-24
pubmed: 22138388
Eur J Cancer. 2015 Dec;51(18):2792-9
pubmed: 26608120
Lancet Oncol. 2016 Jul;17(7):976-983
pubmed: 27267608
Cancer Discov. 2017 Nov;7(11):1266-1283
pubmed: 28899863
N Engl J Med. 2014 Nov 13;371(20):1867-76
pubmed: 25265494
N Engl J Med. 2018 Aug 23;379(8):722-730
pubmed: 30134131
Cancer Cell. 2013 Mar 18;23(3):287-301
pubmed: 23416000

Auteurs

Zeynep Eroglu (Z)

Moffitt Cancer Center, Tampa, Florida.

Sheri L Holmen (SL)

University of Utah Health Sciences Center, Salt Lake City, Utah.

Qing Chen (Q)

The Wistar Institute, Philadelphia, Pennsylvania.

Nikhil I Khushalani (NI)

Moffitt Cancer Center, Tampa, Florida.

Ravi Amaravadi (R)

The University of Pennsylvania, Philadelphia, Pennsylvania.

Reena Thomas (R)

Stanford University, Palo Alto, California.

Kamran A Ahmed (KA)

Moffitt Cancer Center, Tampa, Florida.

Hussein Tawbi (H)

MD Anderson Cancer Center, Houston, Texas.

Sunandana Chandra (S)

Northwestern University, Chicago, Illinois.

Joseph Markowitz (J)

Moffitt Cancer Center, Tampa, Florida.

Inna Smalley (I)

Moffitt Cancer Center, Tampa, Florida.

James K C Liu (JKC)

Moffitt Cancer Center, Tampa, Florida.

Yian Ann Chen (YA)

Moffitt Cancer Center, Tampa, Florida.

Yana G Najjar (YG)

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

Florian A Karreth (FA)

Moffitt Cancer Center, Tampa, Florida.

Daniel Abate-Daga (D)

Moffitt Cancer Center, Tampa, Florida.

Isabella C Glitza (IC)

MD Anderson Cancer Center, Houston, Texas.

Jeffrey A Sosman (JA)

Northwestern University, Chicago, Illinois.

Vernon K Sondak (VK)

Moffitt Cancer Center, Tampa, Florida.

Marcus Bosenberg (M)

Yale University, New Haven, Connecticut.

Meenhard Herlyn (M)

The Wistar Institute, Philadelphia, Pennsylvania.

Michael B Atkins (MB)

Georgetown University Cancer Center, Washington, District of Columbia.

Harriet Kluger (H)

Yale University, New Haven, Connecticut.

Kim Margolin (K)

City of Hope, Duarte, California.

Peter A Forsyth (PA)

Moffitt Cancer Center, Tampa, Florida.

Michael A Davies (MA)

MD Anderson Cancer Center, Houston, Texas.

Keiran S M Smalley (KSM)

Moffitt Cancer Center, Tampa, Florida.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH